cdr
Search

Hot Keywords
Drug Resistance Mechanisms Epigenetic Resistance in Cancer Therapy Biomarkers Pharmacogenetics of Cancer Liquid Biopsy Targeted Cancer Therapy Non-coding RNAs Kinase Inhibitors ABC Transporters

Top
  1. Home
  2. Special Issues
  3. All Special Issues
  4. Special Issue
Topic: The Role of p53 in Cancer Drug Resistance and Targeted Chemotherapy

A special issue of Cancer Drug Resistance

ISSN 2578-532X (Online)

Submission deadline: 1 Nov 2022

Guest Editor(s)

  • Prof. Martin Michaelis

    School of Biosciences, University of Kent, Canterbury, UK.

    Website | E-mail

  • Prof. Jindrich Cinatl Jr

    The Johann Wolfgang Goethe-University, Frankfurt am Main, Germany.

    Website | E-mail

  • Prof. Mark Wass

    School of Biosciences, University of Kent, Canterbury, UK.

    Website | E-mail

Submission Deadline

1 Nov 2022

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to http://cdrjournal.com/pages/view/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=cdr&SpecialIssueId=CDR220406
Submission Deadline: 1 Nov 2022
Contacts: Lori Kang, Assistant Editor, lori@cdrjournal.com

Published Articles

This special issue is now open for submission.
© 2016-2022 OAE Publishing Inc., except certain content provided by third parties